Xue, Xiangdong http://orcid.org/0000-0002-3709-072X
Huang, Yee
Bo, Ruonan
Jia, Bei
Wu, Hao
Yuan, Ye
Wang, Zhongling
Ma, Zhao
Jing, Di
Xu, Xiaobao
Yu, Weimin
Lin, Tzu-yin
Li, Yuanpei http://orcid.org/0000-0002-4015-646X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD086195)
Division of Cancer Prevention, National Cancer Institute (P30CA093373)
Article History
Received: 9 October 2017
Accepted: 14 August 2018
First Online: 7 September 2018
Competing interests
: Y.L., X.X., Y.H. and Z.M. are the co-inventors of the pending patent on the transformable nanoparticles and plan to develop the nanotherapeutics described in the manuscript commercially. The remaining authors declare no competing interests.